Real-world outcomes comparing the use of GLP-1 agonists in patients with multiple myeloma and comorbid obesity: A propensity score–matched analysis from a global federated health research network.Arshi Syal, Gàbor Varadi, Yajur Arya et al.|Journal of Clinical Oncology|2026Cited by 1
Abstract 3994: Differences in the mutational landscape across race and sex highlight distinct TP53-associated risk in multiple myelomaChidiebube Ugwu, Amin Turki, Tarfa Verinumbe et al.|Cancer Research|2026Cited by 0